TP53 and cancer: Mutations in these two genes occur very frequently in GBM; analysis of 601 genes from 91 GBM patient samples, recently completed as part of The Cancer Genome Atlas project, showed the incidence of TP53 and PTEN mutations to be 42% and 33%, respectively [4].